Clinical trial
A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects…
NCT00116103 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00116103 |
|---|---|
| Title | A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma |
| Official title | A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma US, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Tacrolimus Inhalation Aerosol |
| Start date | Jun 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Jun 28, 2005 |
| Last update posted | Jun 7, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: